Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > TALS Talaris Therapeutics > Main Composition
TALS Talaris Therapeutics
1.630
-0.140-7.91%
Post Mkt Price
1.6300.0000.00%
All
YOY
Do not show
Business

No Data

Region

No Data

Company Overview More
Talaris Therapeutics, Inc. engages in cell therapy. It develops methods of allogeneic hematopoietic stem cell transplantation (allo-HSCT). Its technologies are used to treat inherited metabolic enzyme disorders, red blood cell disorders to induce tolerance to organ transplants, and to treat autoimmune disorders such as type 1 diabetes, multiple sclerosis, rheumatoid arthritis, and scleroderma. The company was founded by Suzanne Ildstad on February 15, 2002 and is headquartered in Louisville, KY.
CEO: Mr. Scott Requadt
Market: NASDAQ
Listing Date: 05/07/2021
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist